144 related articles for article (PubMed ID: 31319298)
1. Chemo-sensitizing activity of natural cadinanes from Heterotheca inuloides in human uterine sarcoma cells and their in silico interaction with ABC transporters.
Rodríguez-Chávez JL; Méndez-Cuesta CA; Ramírez-Apan T; Egas V; Ávila JL; Neira-González A; Hernández T; Espinosa-García FJ; Delgado G
Bioorg Chem; 2019 Oct; 91():103091. PubMed ID: 31319298
[TBL] [Abstract][Full Text] [Related]
2. Toxicological evaluation of the natural products and some semisynthetic derivatives of Heterotheca inuloides Cass (Asteraceae).
Rodríguez-Chávez JL; Coballase-Urrutia E; Sicilia-Argumedo G; Ramírez-Apan T; Delgado G
J Ethnopharmacol; 2015 Dec; 175():256-65. PubMed ID: 26344038
[TBL] [Abstract][Full Text] [Related]
3. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
4. Effect of natural and semi-synthetic cadinanes from Heterotheca inuloides on NF-κB, Nrf2 and STAT3 signaling pathways and evaluation of their in vitro cytotoxicity in human cancer cell lines.
Egas V; Millán E; Collado JA; Ramírez-Apan T; Méndez-Cuesta CA; Muñoz E; Delgado G
Bioorg Med Chem; 2017 Jun; 25(12):3135-3147. PubMed ID: 28410869
[TBL] [Abstract][Full Text] [Related]
5. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
[TBL] [Abstract][Full Text] [Related]
6. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship.
Katayama K; Masuyama K; Yoshioka S; Hasegawa H; Mitsuhashi J; Sugimoto Y
Cancer Chemother Pharmacol; 2007 Nov; 60(6):789-97. PubMed ID: 17345086
[TBL] [Abstract][Full Text] [Related]
7. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
8. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
9. ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells.
Mirzaei SA; Gholamian Dehkordi N; Ghamghami M; Amiri AH; Dalir Abdolahinia E; Elahian F
Toxicol Appl Pharmacol; 2017 Dec; 337():22-29. PubMed ID: 29079042
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells.
Abdelfatah SA; Efferth T
Phytomedicine; 2015 Feb; 22(2):308-18. PubMed ID: 25765838
[TBL] [Abstract][Full Text] [Related]
11. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
[TBL] [Abstract][Full Text] [Related]
12. Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin.
Chang CC; Huang LH; Chiang W; Hsia SM
Phytomedicine; 2018 Aug; 47():69-80. PubMed ID: 30166110
[TBL] [Abstract][Full Text] [Related]
13. Novel Anticancer Dimeric Naphthoquinones from
Rauf A; Khan A; Abu-Izneid T; Alhumaydhi FA; Bawazeer S; Raza M; Khan H; Patel S; Al-Harrasi A
Anticancer Agents Med Chem; 2021; 21(15):2089-2097. PubMed ID: 33438565
[TBL] [Abstract][Full Text] [Related]
14. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
15. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY.
Angelini A; Ciofani G; Conti P
J Biol Regul Homeost Agents; 2015; 29(2):357-65. PubMed ID: 26122223
[TBL] [Abstract][Full Text] [Related]
16. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance.
Karthikeyan S; Hoti SL
Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell lines.
Elahian F; Kalalinia F; Behravan J
Drug Chem Toxicol; 2010 Apr; 33(2):113-9. PubMed ID: 20307139
[TBL] [Abstract][Full Text] [Related]
18. Marine natural products as breast cancer resistance protein inhibitors.
Cherigo L; Lopez D; Martinez-Luis S
Mar Drugs; 2015 Apr; 13(4):2010-29. PubMed ID: 25854646
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells.
Saeed MEM; Boulos JC; Elhaboub G; Rigano D; Saab A; Loizzo MR; Hassan LEA; Sugimoto Y; Piacente S; Tundis R; Yagi S; Khalid H; Efferth T
Phytomedicine; 2019 Sep; 62():152945. PubMed ID: 31132750
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
Gao M; Xu Y; Qiu L
J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
